AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
PolyPid Ltd. Ordinary Shares
XNAS · usd
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG002Q6KV48
5.25▲ 0.12 (2.34%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
—
EV / Revenue
—
EV / EBITDA
Financial Highlights
Revenue (TTM)
—
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
—
Net Debt
Trading Information
Previous Close
5.13
Day's Range
5.11 – 5.25
52-Week Range
3.14 – 5.73
Volume
103.5K
Avg Volume
98.4K
Share Statistics
Shares Outstanding
Employees
75
Exchange
XNAS
Listed
2020-06-26
Share count as of December 31, 2025

PolyPid Ltd. Ordinary Shares (PYPD) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about PolyPid Ltd. Ordinary Shares (PYPD)
What is PolyPid Ltd. Ordinary Shares's Market Cap?
PolyPid Ltd. Ordinary Shares's Market Cap is $95.6M, based on as-reported figures from SEC (XBRL) filings.
What is PolyPid Ltd. Ordinary Shares's Enterprise Value?
PolyPid Ltd. Ordinary Shares's Enterprise Value is $90.2M, based on as-reported figures from SEC (XBRL) filings.
What is PolyPid Ltd. Ordinary Shares's EV / EBITDA?
PolyPid Ltd. Ordinary Shares's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is PolyPid Ltd. Ordinary Shares's Net Income (TTM)?
PolyPid Ltd. Ordinary Shares's Net Income (TTM) is -$34.2M, based on as-reported figures from SEC (XBRL) filings.
What is PolyPid Ltd. Ordinary Shares's EBITDA?
PolyPid Ltd. Ordinary Shares's EBITDA is -$31.5M, based on as-reported figures from SEC (XBRL) filings.
What is PolyPid Ltd. Ordinary Shares's Diluted EPS (TTM)?
PolyPid Ltd. Ordinary Shares's Diluted EPS (TTM) is -1.88, based on as-reported figures from SEC (XBRL) filings.
What is PolyPid Ltd. Ordinary Shares's Net Debt?
PolyPid Ltd. Ordinary Shares's Net Debt is -$5.4M, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · PYPDAs-filed SEC (XBRL) data
No Quarterly data available for this company — showing Annual instead. This company files annual reports only — foreign private issuers (Form 20-F / 40-F) are not required to file quarterly reports, so no quarterly figures exist to show.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018
Operating expenses:
Research and development
Marketing and business development
General and administrative
Operating loss
Loss on extinguishment of debt
Financial expense, net
Loss before income tax
Income tax expense
Net loss
Basic (in Dollars per share)
Diluted (in Dollars per share)